Find More Contacts for F2G
Protected Content
Non-Management, VP Operations
2 emails found
View contacts for F2G to access new leads and connect with decision-makers.
View All Contacts
  • Company Type For Profit
  • Contact Email contact@f2g.com
  • Phone Number 44 (0)161 785 1270

F2G is advancing its own patented compounds and technologies which will lead to the development of novel agents to treat serious fungal disease. The Company was founded on its proprietary genomics technology (MycoBank®) that identifies essential gene targets in fungi. Having received initial funding in 2002 the company then rapidly diversified

into chemistry-driven discovery. They have also assembled an experienced development capacity.

Lists Featuring This Company

Health Care Private Equity Stage Companies With Less Than $50M in Revenue
654 Number of Organizations • $17.3B Total Funding Amount • 1,314 Number of Investors
Europe Private Equity Stage Companies With Less Than $10M in Revenue
868 Number of Organizations • $20.3B Total Funding Amount • 1,607 Number of Investors
Medical Companies With Fewer Than 1000 Employees (Top 10K)
9,763 Number of Organizations • $356.9B Total Funding Amount • 32,817 Number of Investors
Private Equity Funded Companies (Top 10K)
9,966 Number of Organizations • $3.3T Total Funding Amount • 114,459 Number of Investors

Frequently Asked Questions

Where is F2G's headquarters? F2G is located in Manchester, Manchester, United Kingdom.Who invested in F2G? F2G has 20 investors including Forbion Capital Partners and Sofinnova Partners.How much funding has F2G raised to date? F2G has raised .When was the last funding round for F2G? F2G closed its last funding round on Aug 4, 2022 from a Private Equity round.Who are F2G's competitors? Alternatives and possible competitors to F2G may include Travere TherapeuticsCEL-SCI, and Affimed.